Overview
This study is to evaluate the effectiveness and safety of Ultimaster Tansei stent in the "real-world" daily practice.
Eligibility
Inclusion Criteria:
- Patients ≥ 19 years old
- Patients receiving Ultimaster™ Tansei™ stents.
- The patient or guardian agrees to the study protocol and the schedule of clinical follow-up and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.
Exclusion Criteria:
- Patients with a mixture of other drug-eluting stents (DESs)
- Terminal illness with life-expectancy ≤1 year.
- Patients with cardiogenic shock